PROLONGED ACTION-POTENTIAL DURATION AND POSITIVE INOTROPY INDUCED BY THE NOVEL CLASS-III ANTIARRHYTHMIC AGENT H-234/09 (ALMOKALANT) IN ISOLATED HUMAN VENTRICULAR MUSCLE

被引:32
作者
CARLSSON, L
ABRAHAMSSON, C
ALMGREN, O
LUNDBERG, C
DUKER, G
机构
[1] Preclinical Research and Development, Astra Hässle, Mölndal
关键词
ARRHYTHMIAS; ANTIARRHYTHMIC THERAPY; DELAYED REPOLARIZATION; CLASS-III; INOTROPY;
D O I
10.1097/00005344-199112000-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The electromechanical properties of H 234/09 (Almokalant), a novel class III antiarrhythmic agent, was examined in isolated human ventricular muscle strips excised from patients undergoing mitral valve replacement. Using transmembrane microelectrode recording techniques, we demonstrated that H 234/09 markedly prolonged the action potential duration (APD) without affecting the maximal rate of depolarization or action potential amplitude. At 75 and 90% repolarization APD was prolonged to a similar extent, whereas the lengthening at 50% repolarization was somewhat less marked. In isometrically contracting muscle strips, H 234/09 increased peak developed force and its maximal rate of rise (dF/dt) and fall (-dF/dt) in a concentration-dependent manner, whereas time to peak developed force was unaltered. We conclude from these studies that H 234/09 is a class III agent in human ventricular muscle and that the class III effect is linked with a positive inotropic response.
引用
收藏
页码:882 / 887
页数:6
相关论文
共 19 条
[2]   ANTIARRHYTHMIC DRUG EFFECTS ON LEFT-VENTRICULAR PERFORMANCE [J].
BOURKE, JP ;
COWAN, JC ;
TANSUPHASWADIKUL, S ;
CAMPBELL, RWF .
EUROPEAN HEART JOURNAL, 1987, 8 :105-111
[3]  
CARLSSON L, 1990, EUR HEART J S, V11
[4]  
CARMELIET E, 1991, Journal of Molecular and Cellular Cardiology, V23, pS79, DOI 10.1016/0022-2828(91)90752-8
[5]   NEGATIVE LUSITROPIC EFFECT OF DPI-201-106 AND E4031 - POSSIBLE ROLE OF PROLONGING ACTION-POTENTIAL DURATION [J].
CINGOLANI, HE ;
WIEDMANN, RT ;
LYNCH, JJ ;
WENGER, HC ;
SCOTT, AL ;
SIEGL, PKS ;
STEIN, RB .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1990, 22 (09) :1025-1034
[6]   CHANNEL SPECIFICITY IN ANTIARRHYTHMIC DRUG-ACTION - MECHANISM OF POTASSIUM CHANNEL BLOCK AND ITS ROLE IN SUPPRESSING AND AGGRAVATING CARDIAC-ARRHYTHMIAS [J].
COLATSKY, TJ ;
FOLLMER, CH ;
STARMER, CF .
CIRCULATION, 1990, 82 (06) :2235-2242
[7]  
DUKER G D, 1990, Journal of Molecular and Cellular Cardiology, V22, pS82, DOI 10.1016/0022-2828(90)91772-Y
[8]   ARRHYTHMIAS IN ISCHEMIC AND NONISCHEMIC DILATED CARDIOMYOPATHY - PREDICTION OF MORTALITY BY AMBULATORY ELECTROCARDIOGRAPHY [J].
HOLMES, J ;
KUBO, SH ;
CODY, RJ ;
KLIGFIELD, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (01) :146-151
[9]   CLASS-III ANTIARRHYTHMIC AGENTS HAVE A LOT OF POTENTIAL BUT A LONG WAY TO GO - REDUCED EFFECTIVENESS AND DANGERS OF REVERSE USE DEPENDENCE [J].
HONDEGHEM, LM ;
SNYDERS, DJ .
CIRCULATION, 1990, 81 (02) :686-690
[10]  
HONERJAGER P, 1986, BASIC RES CARDIOL, V81, P33